Skip to main content
ACG 2025 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream

Tuesday Poster Session

Category: Colon

P4583 - Epidemiological Trends and Survival Outcomes of Early Onset Colon and Rectal Cancer: An Analysis of SEER 2018-2022 Data Among Patients Under 50 Years

Tuesday, October 28, 2025
10:30 AM - 4:00 PM MT
Location: Exhibit Hall
Imran Khan, MD1, Shahzaib Maqbool, MBBS2, Aria Khan, MD1, Umar Bazai, MD3, Adil Khan, MBBS4, Shahzad Zafar, MD5, Arslan Kareem, MBBS2, Pouyan Gohari, MD6
1NYC Health + Hospitals/Woodhull, Jamaica, NY; 2Rawalpindi Medical University, Rawalpindi, Punjab, Pakistan; 3Charleston Area Medical Centre, Charleston, WV; 4University of Louisville, Louisville, KY; 5Howard University Hospital, Washington, DC; 6NYC Health + Hospitals/Woodhull, Brooklyn, NY

Introduction: Early-onset colorectal cancer (CRC), defined as diagnosis before 50 years of age, has emerged as a significant clinical challenge despite traditionally lower incidence in younger populations. Understanding incidence rates and survival trends in this demographic is critical for targeted public health interventions and optimized clinical management.

Methods: We analyzed data from the Surveillance, Epidemiology, and End Results (SEER) Program covering 2018–2022, focusing on colon and rectal cancers (including appendix) in patients under 50 years. Age-adjusted incidence rates per 100,000 population and 5-year relative survival trends were examined. Incidence rates included 95% confidence intervals (CI). Survival trends assessed average annual absolute changes with associated 95% CIs, highlighting directionality over a 22-year period (2000–2022).

Results: The age-adjusted incidence rate for patients under 50 was 9.0 per 100,000 (95% CI: 8.9–9.1), representing 42,645 cases out of a total 319,746 SEER cases across all ages. Analysis of 5-year relative survival revealed a statistically significant decline, with an average annual decrease of –0.4% (95% CI: –0.7 to –0.2), indicating worsening survival outcomes in younger patients despite advances in cancer care.

Discussion: Our findings reveal a concerning rise in early-onset colorectal cancer incidence paired with a declining 5-year survival rate among patients under 50 years. This trend underscores the need for heightened awareness, earlier screening strategies, and tailored therapeutic approaches for this vulnerable group. Future research should explore biological, environmental, and socioeconomic factors contributing to these trends to improve outcomes.

Disclosures:
Imran Khan indicated no relevant financial relationships.
Shahzaib Maqbool indicated no relevant financial relationships.
Aria Khan indicated no relevant financial relationships.
Umar Bazai indicated no relevant financial relationships.
Adil Khan indicated no relevant financial relationships.
Shahzad Zafar indicated no relevant financial relationships.
Arslan Kareem indicated no relevant financial relationships.
Pouyan Gohari indicated no relevant financial relationships.

Imran Khan, MD1, Shahzaib Maqbool, MBBS2, Aria Khan, MD1, Umar Bazai, MD3, Adil Khan, MBBS4, Shahzad Zafar, MD5, Arslan Kareem, MBBS2, Pouyan Gohari, MD6. P4583 - Epidemiological Trends and Survival Outcomes of Early Onset Colon and Rectal Cancer: An Analysis of SEER 2018-2022 Data Among Patients Under 50 Years, ACG 2025 Annual Scientific Meeting Abstracts. Phoenix, AZ: American College of Gastroenterology.